medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2018, Number 4

<< Back Next >>

Rev Mex Oftalmol 2018; 92 (4)

Clinical characteristics and etiology of low vision and blindness in an adult population with visual impairment

Arias-Uribe J, Llano-Naranjo Y, Astudillo-Valverde E, Suárez-Escudero JC

Language: Spanish
References: 47
Page: 201-208
PDF size: 198.00 Kb.


ABSTRACT

Introduction: low vision and blindness make up the visual disability, one of the types of disability with the highest worldwide prevalence, and apparently the most frequent at a Colombian level. The conventional etiology of permanent and transitory deficiencies responsible for visual impairment such as glaucoma, cataract, infectious blindness and uncorrected ametropias, may be changing due to the presence of other entities and results of public health programs, and it is necessary to extend the etiological spectrum to both Ophthalmological causes as not ophthalmological. Objectives: to identify the etiology and the most relevant clinical characteristics in an adult population with visual impairment. Materials and methods: descriptive cross-sectional study in 96 adults with confirmed visual impairment. Results: 61% with low vision; in 55% the etiology of the visual deficiency was in the posterior segment, 21% in the anterior segment and 10% in the pathway and/or visual cortex. The most frequent individual pathologies: pathological myopia, non-glaucomatous optic neuropathy, glaucoma and macular degeneration related to age. Conclusions: in this study, pathologies with posterior segment involvement occupied the most frequent etiologies related to visual disability, and the neuro ophthalmological and ocular trauma entities were identified as a potential source of visual deficiencies. It is necessary to continue carrying out studies that clarify whether the spectrum of conventional etiologies causing visual disability has changed, with the aim of redirecting programs of promotion, prevention, diagnosis, treatment and rehabilitation in low vision and blindness.


REFERENCES

  1. Poma PA. Disability and Culture. Universalism and Diversity. J Natl Med Assoc. 2005;97(3):428.

  2. OMS. Plan de acción mundial de la OMS sobre discapacidad 2014-2021 [Internet]. Consultado el 29 de enero de 2017. Disponible en: http://www. who.int/disabilities/actionplan/es/.

  3. WHO. World report on disability. [Internet]. Consultado el 29 de enero de 2017. Disponible en: http://www.who.int/disabilities/world_report/ 2011/en/.

  4. Pan American Health Organization/World Health Organization. OPS OMS. Clasificación de Funcionamiento y Discapacidad. [Internet]. Citado el 29 de enero de 2017. Disponible en: http://www.paho.org/hq/index. php?option=com_content&view=article&id=3562%3A2010-clasificacion- internacional-funcionamiento-discapacidad-salud-cif&catid= 511%3Ahealth-information-analysis&Itemid=2561&lang=es.

  5. Stevens GA, White RA, Flaxman SR, Price H, Jonas JB, Keeffe J, et al. Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990-2010. Ophthalmology. 2013;120(12):2377-84.

  6. WHO. Blindness and vision impairment prevention. [Internet]. Consultado el 24 de marzo de 2018. Disponible en: http://www.who.int/blindness/ world_sight_day/2017/en/#.

  7. Censo general 2005. [Internet]. Consultado el 29 de enero de 2017. Disponible en: https://www.dane.gov.co/index.php/estadisticas-por-tema/ demografia-y-poblacion/censo-general-2005-1.

  8. Moreno Angarita M, Ximena Rubio Viscaya S. Realidad y contexto situacional de la población con limitación visual en Colombia: una aproximación desde la justicia y el desarrollo humano. Primera Ed. Bogotá DC: Imprenta Braille del Instituto Nacional para Ciegos; 2011. [Internet]. Disponible en: http://www.inci.gov.co.

  9. Epidemiología de la Baja Visión en Latinoamérica y Chile. VISIÓN 2020. 2013. [Internet]. Consultado el 29 de enero de 2017. Disponible en: https:// vision2020la.wordpress.com/2013/11/01/epidemiologia-de-la-baja- vision-en-latinoamerica-y-chile/.

  10. WHO. News. [Internet]. Consultado el 29 de enero de 2017. Disponible en: http://www.who.int/blindness/en/.

  11. Miqueli-Rodríguez M, López-Hernández SM, Rodríguez-Masó S. Baja visión y envejecimiento de la población. Rev Cuba Oftalmol. 2016;29(3):492-501.

  12. van Leeuwen LM, Rainey L, Kef S, van Rens GHMB, van Nispen RMA. Investigating rehabilitation needs of visually impaired young adults according to the International Classification of Functioning, Disability and Health. Acta Ophthalmol (Copenh). 2015;93(7):642-50.

  13. Ramrattan RS, Wolfs RC, Panda-Jonas S, Jonas JB, Bakker D, Pols HA, et al. Prevalence and causes of visual field loss in the elderly and associations with impairment in daily functioning: the Rotterdam Study. Arch Ophthalmol Chic Ill 1960. 2001;119(12):1788-94.

  14. Stevens GA, White RA, Flaxman SR, Price H, Jonas JB, Keeffe J, et al. Global prevalence of vision impairment and blindness: magnitude and temporal trends, 1990-2010. Ophthalmology. 2013;120(12):2377-84.

  15. Oviedo MP, Hernández ML, Ruíz M. Low vision in Colombia: an invisible situation for the country. Rev Fac Nac Salud Pública. 2015;33(1): 22-30.

  16. Escudero JC. Discapacidad visual y ceguera en el adulto: revisión de tema. Med UPB. 2011;30(2):170-80.

  17. Finger RP, Bertram B, Wolfram C, Holz FG. Blindness and visual impairment in Germany: a slight fall in prevalence. Dtsch Arzteblatt Int. 2012;109(27-28):484-9.

  18. Resnikoff S, Pascolini D, Etya’ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82(11):844-51.

  19. Rojas S, Ruiz S, Carvajal J, Álvarez MJ, Duque D, Correa SA, et al. Caracterización de una población con discapacidad visual (baja visión y ceguera) atendida en dos Instituciones Prestadoras de Salud de Medellín. Med UPB. 2015;34(1):30-39.

  20. Furtado JM, Lansingh VC, Carter MJ, Milanese MF, Peña BN, Ghersi HA, et al. Causes of blindness and visual impairment in Latin America. Surv Ophthalmol. 2012;57(2):149-77.

  21. Pathologic Myopia-Clinical Key. [Internet]. Consultado el 29 de enero de 2017. Disponible en: https://www-clinicalkey-es.consultaremota.upb.edu. co/#!/content/book/3-s2.0-B9781416000167501570.

  22. Tano Y. Pathologic myopia: where are we now? Am J Ophthalmol. 2002;134(5):645-60.

  23. Pathologic myopia (myopic degeneration) - EyeWiki. [Internet]. Consultado el 29 de enero de 2017. Disponible en: http://eyewiki.aao.org/Pathologic_ myopia_(myopic_degeneration).

  24. Ohno-Matsui K, Lai TY, Lai CC, Cheung CM. Updates of pathologic myopia. Prog Retin Eye Res. 2016;52:156-87.

  25. Yamada M, Hiratsuka Y, Roberts CB, Pezzullo ML, Yates K, Takano S, et al. Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections. Ophthalmic Epidemiol. 2010;17(1):50-7.

  26. Cedrone C, Nucci C, Scuderi G, Ricci F, Cerulli A, Culasso F. Prevalence of blindness and low vision in an Italian population: a comparison with other European studies. Eye Lond Engl. 2006;20(6):661-7.

  27. Spooner K, Hong T, Wijeyakumar W, Chang AA. Switching to aflibercept among patients with treatment-resistant neovascular age-related macular degeneration: a systematic review with meta-analysis. Clin Ophthalmol. 2017;11:161-77.

  28. Pennington KL, DeAngelis MM. Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors. Eye Vis (Lond). 2016;3:34.

  29. Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106-116.

  30. Eduardo Leite Arieta C, Nicolini Delgado AM, José NK, Temporini ER, Alves MR, de Carvalho Moreira Filho D. Refractive errors and cataract as causes of visual impairment in Brazil. Ophthalmic Epidemiol. 2003;10(1):15-22.

  31. Cass H, Landers J, Benitez P. Causes of blindness among hospital outpatients in Ecuador. Clin Experiment Ophthalmol. 2006;34(2):146-51.

  32. Strong S, Liew G, Michaelides M. Retinitis pigmentosa-associated cystoid macular oedema: pathogenesis and avenues of intervention. Br J Ophthalmol. 2017;101(1):31-7.

  33. Zhang Q. Retinitis Pigmentosa: Progress and Perspective. Asia-Pac J Ophthalmol Phila Pa. 2016;5(4):265-71.

  34. Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet Lond Engl. 2006;368(9549):1795-809.

  35. Prevalencia de ceguera en Colombia. Estudio poblacional en una comunidad urbana. 26/2/2004. [Internet]. Consultado el 29 de enero de 2017. Disponible en: http://www.pagina-digital.com.ar/articulos/2004/2004prim/ tecnologia2/vis24-2pl.asp.

  36. Prevalencia de ceguera en el Departamento de Santander - Colombia. ResearchGate. [Internet]. Consultado el 29 de enero de 2017. Disponible en: https://www.researchgate.net/publication/26848459_Prevalencia_de_ ceguera_en_el_Departamento_de_Santander_-_Colombia.

  37. Rodríguez FJ, Brieke AC, Guerrero J, Porras A, Zarabanda MP. Prevalencia de retinopatía diabética en consulta privada en Bogotá, Colombia desde el 2000 hasta el 2007. Rev Soc Colomb Oftalmol. 2009;42(2):197- 204.

  38. Zuluaga C, Sierra MV, Asprilla E. Causas de ceguera infantil en Cali, Colombia. Colombia Médica. 2005. [Internet]. Consultado el 29 de enero de 2017. Disponible en: http://www.redalyc.org/articulo.oa?id=28336402.

  39. Cañón Cárdenas YZ. La baja visión en Colombia y en el mundo. Cien Tecnol Salud Vis Ocul. 2011;9(1):117-23.

  40. Suárez-Escudero JC. Discapacidad y neurociencias: la magnitud del déficit neurológico y neuropsiquiátrico. Acta Neurológica Colomb. 2014;30(4):290-9.

  41. Quillen DA. Common causes of vision loss in elderly patients. Am Fam Physician. 1999;60(1):99-108.

  42. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96(5):614-8.

  43. Abou-Gareeb I, Lewallen S, Bassett K, Courtright P. Gender and blindness: a meta-analysis of population-based prevalence surveys. Ophthalmic Epidemiol. 2001;8(1):39-56.

  44. Olatunji VA, Adepoju FG, Owoeye JF. Perception and Attitude of a Rural Community Regarding Adult Blindness in North Central Nigeria. Middle East Afr J Ophthalmol. 2015;22(4):508-13.

  45. Yonekawa Y, Varma R, Choudhury F, Torres M, Azen SP, Los Angeles Latino Eye Study Group. Risk factors for four-year incident visual impairment and blindness: the Los Angeles Latino Eye Study. Ophthalmology. 2011;118(9):1790-7.

  46. Liu JH, Cheng CY, Chen SJ, Lee FL. Visual impairment in a Taiwanese population: prevalence, causes, and socioeconomic factors. Ophthalmic Epidemiol. 2001;8(5):339-50.

  47. Centers for Disease Control and Prevention (CDC). Reasons for not seeking eye care among adults aged ≥ 40 years with moderate-to-severe visual impairment--21 States, 2006-2009. MMWR Morb Mortal Wkly Rep. 2011;60(19):610-3.




2020     |     www.medigraphic.com